filings.toolsItem 16. Form 10-K Summary
5K characters. Original on sec.gov · Markdown
Item 16. Form 10-K Summary
None.
SIGNATURES
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized, on the 11th day of February 2021.
| ZEBRA TECHNOLOGIES CORPORATION | ||
| By: /s/ Anders Gustafsson | ||
| Anders Gustafsson | ||
| Chief Executive Officer |
Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons in the capacities and on the dates indicated.
| Signature | Title | Date | ||||||
| /s/ Anders Gustafsson Anders Gustafsson | Chief Executive Officer and Director (Principal Executive Officer) | February 11, 2021 | ||||||
| /s/ Nathan Winters Nathan Winters | Chief Financial Officer (Principal Financial Officer) | February 11, 2021 | ||||||
| /s/ Colleen M. O’Sullivan Colleen M. O’Sullivan | Vice President, Chief Accounting Officer (Principal Accounting Officer) | February 11, 2021 | ||||||
| /s/ Michael A. Smith Michael A. Smith | Director and Chairman of the Board of Directors | February 11, 2021 | ||||||
| /s/ Linda M. Connly Linda M. Connly | Director | February 11, 2021 | ||||||
| /s/ Ross W. Manire Ross W. Manire | Director | February 11, 2021 | ||||||
| /s/ Richard L. Keyser Richard L. Keyser | Director | February 11, 2021 | ||||||
| /s/ Janice M. Roberts Janice M. Roberts | Director | February 11, 2021 | ||||||
| /s/ Chirantan J. Desai Chirantan J. Desai | Director | February 11, 2021 | ||||||
| /s/ Frank B. Modruson Frank B. Modruson | Director | February 11, 2021 |
ZEBRA TECHNOLOGIES CORPORATION AND SUBSIDIARIES
Schedule II
Valuation and Qualifying Accounts
(In millions)
| Additions | ||||||||||||||||||||||||||||||||
| Description | Balance at Beginning of Period | Charged to Costs and Expenses | Charged to Other Accounts**(1)** | Deductions | Balance at End of Period | |||||||||||||||||||||||||||
| Valuation account for accounts receivable: | ||||||||||||||||||||||||||||||||
| Year ended December 31, 2020 | $ | 2 | $ | (1) | $ | — | $ | — | $ | 1 | ||||||||||||||||||||||
| Year ended December 31, 2019 | 3 | — | — | 1 | 2 | |||||||||||||||||||||||||||
| Year ended December 31, 2018 | 3 | 1 | — | 1 | 3 | |||||||||||||||||||||||||||
| Valuation account for deferred tax assets: | ||||||||||||||||||||||||||||||||
| Year ended December 31, 2020 | $ | 421 | $ | 1 | $ | 3 | $ | 12 | $ | 413 | ||||||||||||||||||||||
| Year ended December 31, 2019 | 56 | 6 | 375 | 16 | 421 | |||||||||||||||||||||||||||
| Year ended December 31, 2018 | 134 | — | — | 78 | 56 |
(1)The amount in 2020 primarily included increases to our valuation allowance related to business combination purchase price allocation adjustments. The amount in 2019 related to Luxembourg reorganization activities, which resulted in the realization of deferred tax liabilities related to depreciation and amortization and a corresponding increase in valuation allowances, with no net impact to our provision for income taxes. See Note 16, Income Taxes in the Notes to Consolidated Financial Statements for further information.
See accompanying report of independent registered public accounting firm.
Previous: Item 15. Exhibits, Financial Statements and Schedules